Latest filing published 13 May 2015 for HTG Molecular Diagnostics, INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Fletcher Spaght Ventures II LP: trading record in brief
This profile gathers the share dealings of Fletcher Spaght Ventures II LP in HTG Molecular Diagnostics, Inc. Altogether 5 filings, all relating to 11 May 2015.
Every open-market trade on record is a purchase: 1 purchase worth €1.3M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 13 May 2015: a transaction, in HTG Molecular Diagnostics, Inc. The last purchase on record was published on 13 May 2015, which is 4,198 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Fletcher Spaght Ventures II LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 246,727 sharesCommon StockSEC:0001209191-15-042266:0
- 56,718 sharesCommon StockSEC:0001209191-15-042266:1
- 44,301 shares@ US$14.00Common StockSEC:0001209191-15-042266:2
- 68,404 shares0Common StockSEC:0001209191-15-042266:3
- 102,445 shares@ US$14.00Common StockSEC:0001209191-15-042266:4Canonical exit: 9 Aug 2015 (T+90)
5 of 5 declarations